Portfolio

We invest in digital health solutions that improve cancer patient journey, transform pharmaceutical R&D, and shift towards more patient centric healthcare.

In the area of disruptive therapeutic platforms we invest in solutions focused on gene and cell therapies.

Current investments

Past investments